WIN 54954

• Description :

  WIN 54954 is an orally active and broad-spectrum antipicornavirus agent. WIN 54954 is effectiveness against human rhinovirus, echovirus 9 and enterovirus infections[1][2].

• CAS Number :

  [107355-45-3]

• UNSPSC :

  12352005

• Target :

  Enterovirus

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-anti-virus

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/win-54954.html

• Purity :

  98.14

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  ClC1=C(OCCCCCC2=CC(C)=NO2)C(Cl)=CC(C3=NCCO3)=C1

• Molecular Formula :

  C18H20Cl2N2O3

• Molecular Weight :

  383.27

• References & Citations :

  [1]Woods MG, et, al. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrob Agents Chemother. 1989 Dec;33 (12) :2069-74.|[2]Fechner H, et, al. Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections. Molecules. 2011 Oct 11;16 (10) :8475-503.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, protect from light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported